Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 2, 2023

Progress on Cholesterol Metabolism in Osteoarthritis

Download as PDF

DOI: 10.23977/medsc.2023.040208 | Downloads: 5 | Views: 333

Author(s)

Xi Zhang 1, Youhuan Hu 1, Shumei Wang 1, Jianghua Xie 2

Affiliation(s)

1 School of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China
2 Dianjiang County Hospital of Traditional Chinese Medicine, Chongqing 408300, China

Corresponding Author

Shumei Wang

ABSTRACT

Studies on risk factors of Osteoarthritis (OA) suggest that patients with OA are associated with abnormal lipid metabolism, and hyperlipidemia may also be a risk factor for OA. In this paper, we review the crucial role of metabolic syndrome in the pathology of Osteoarthritis, investigate the relationship between osteoarthritis and TC levels, clarify the association between cholesterol levels and chondrocytes, oxidative stress, and the therapeutic means to alleviate Osteoarthritis by regulating cholesterol levels.

KEYWORDS

Osteoarthritis, Cholesterol, Chondrocytes, Oxidative stress

CITE THIS PAPER

Xi Zhang, Youhuan Hu, Shumei Wang, Jianghua Xie, Progress on Cholesterol Metabolism in Osteoarthritis. MEDS Clinical Medicine (2023) Vol. 4: 48-53. DOI: http://dx.doi.org/10.23977/medsc.2023.040208.

REFERENCES

[1] Loeser R F, Goldring SR, Scanzello C R, et al. Osteoarthritis: a disease of the joint as an organ[J]. Arthritis Rheum, 2012,64(6):1697-1707.DOI:10.1002/art.34453.
[2] Moon P M, Beier F. Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice[J]. Curr Rheumatol Rep, 2015,17(8):50.DOI:10.1007/s11926-015-0524-1.
[3] Mandl L A. Osteoarthritis year in review 2018: clinical[J].Osteoarthritis Cartilage, 2019,27(3):359-364.DOI:10.1016/j.joca.2018.11.001.
[4] Wallace I J, Worthington S, Felson D T, et al.Knee osteoarthritis has doubled in prevalence since the mid-20th century[J]. Proc Natl Acad Sci U S A, 2017,114(35):9332-9336.DOI:10.1073/pnas.1703856114.
[5] Hunter D J, Schofield D, Callander E. The personal and socioeconomic impact of Osteoarthritis [J].Nat Rev Rheumatol, 2014,10(7):437-441.DOI:10.1038/nrrheum.2014.44.
[6] Hunter D J, Bierma-Zeinstra S. Osteoarthritis[J].Lancet, 2019,393(10182):1745-1759.DOI:10.1016/S0140-6736(19)30417-9.
[7] Farnaghi S, Crawford R, Xiao Y, et al. Cholesterol metabolism in the pathogenesis of osteoarthritis disease[J]. Int J Rheum Dis, 2017,20(2):131-140.DOI:10.1111/1756-185X.13061.
[8] Hart D J, Doyle D V, Spector T D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study[J]. J Rheumatol, 1995,22(6):1118-1123.
[9] Sturmer T, Sun Y, Sauerland S, et al. Serum cholesterol and Osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study[J].J Rheumatol, 1998,25(9):1827-1832.
[10] Addimanda O, Mancarella L, Dolzani P, et al. Clinical associations in patients with hand osteoarthritis[J]. Scand J Rheumatol, 2012,41(4):310-313.DOI:10.3109/03009742.2012.656699.
[11] Davies-Tuck M L, Hanna F, Davis SR, et al. Total Cholesterol and triglycerides are associated with developing new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study[J]. Arthritis Res Ther, 2009,11(6): R181.DOI:10.1186/ar2873.
[12] Cillero-Pastor B, Eijkel G, Kiss A, et al. Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage[J]. Anal Chem, 2012,84(21):8909-8916. DOI:10.1021/ac301853q.
[13] Tsezou A, Iliopoulos D, Malizos K N, et al. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes[J]. J Orthop Res, 2010,28(8):1033-1039.DOI:10.1002/jor.21084.
[14] Prasad K, Lee P. Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin[J]. J Cardiovasc Pharmacol Ther, 2003,8(1):61-69.DOI:10.1177/107424840300800i109.
[15] Arai Y, Choi B, Kim B J, et al. Tauroursodeoxycholic acid (TUDCA) counters Osteoarthritis by regulating intracellular cholesterol levels and membrane fluidity of degenerated chondrocytes[J]. Biomater Sci, 2019,7(8):3178-3189.DOI:10.1039/c9bm00426b.
[16] Kostopoulou F, Gkretsi V, Malizos K N, et al. Central role of SREBP-2 in the pathogenesis of Osteoarthritis [J].PLoS One, 2012,7(5):e35753.DOI:10.1371/journal.pone.0035753.
[17] De Munter W, van der Kraan P M, van den Berg WB, et al. High systemic levels of low-density lipoprotein cholesterol fuel the flames in inflammatory Osteoarthritis?[J]. Rheumatology (Oxford), 2016,55(1):16-24.DOI:10.1093/rheumatology/kev270.
[18] De Munter W, Blom A B, Helsen M M, et al. Cholesterol accumulation caused by low-density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental Osteoarthritis [J].Arthritis Res Ther, 2013,15(6): R178.DOI:10.1186/ar4367.
[19] German L M, van der Ham F, Koudijs A, et al.Metabolic stress-induced inflammation plays a significant role in the development of Osteoarthritis in mice[J]. Arthritis Rheum, 2012,64(4):1172-1181.DOI:10.1002/art.33443.
[20] German L M, Kuhnast S, Koudijs A, et al. Osteoarthritis development is induced by increased dietary Cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis[J].Ann Rheum Dis, 2014,73(5):921-927.DOI:10.1136/annrheumdis-2013-203248.
[21] Sophia F A, Bedi A, Rodeo S A. The basic science of articular cartilage: structure, composition, and function[J]. Sports Health, 2009,1(6):461-468.DOI:10.1177/1941738109350438.
[22] Dreier R. Hypertrophic differentiation of chondrocytes in Osteoarthritis: the developmental aspect of degenerative joint disorders[J].Arthritis Res Ther, 2010,12(5):216.DOI:10.1186/ar3117.
[23] Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications[J]. J Clin Invest, 2002,110(7):905-911.DOI:10.1172/JCI16452.
[24] Yang S T, Kreutzberger A, Lee J, et al. The role of Cholesterol in membrane fusion[J]. Chem Phys Lipids, 2016,199:136-143.DOI:10.1016/j.chemphyslip.2016.05.003.
[25] Holthuis J C, Menon A K. Lipid landscapes and pipelines in membrane homeostasis[J].Nature, 2014,510(7503):48-57.DOI:10.1038/nature13474.
[26] Evans E, Rawicz W. Entropy-driven tension and bending elasticity in condensed-fluid membranes[J].Phys Rev Lett, 1990,64(17):2094-2097.DOI:10.1103/PhysRevLett.64.2094.
[27] Pan J, Tristram-Nagle S, Nagle J F. Effect of Cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation[J].Phys Rev E Stat Nonlin Soft Matter Phys, 2009,80(2 Pt 1):21931.DOI:10.1103/PhysRevE.80.021931.
[28] Ikonen E. Cellular cholesterol trafficking and compartmentalization[J].Nat Rev Mol Cell Biol, 2008,9(2):125-138.DOI:10.1038/nrm2336.
[29] Kwik J, Boyle S, Fooksman D, et al. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin[J]. Proc Natl Acad Sci U S A, 2003,100(24):13964-13969.DOI:10.1073/pnas.2336102100.
[30] Chen C L, Chen C Y, Chen Y P, et al. Betulinic acid enhances TGF-beta signaling by altering TGF-beta receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells[J].J Biomed Sci, 2016,23:30.DOI:10.1186/s12929-016-0229-4.
[31] Chen C L, Liu I H, Fliesler S J, et al. Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis[J].J Cell Sci, 2007,120(Pt 20):3509-3521.DOI:10.1242/jcs.006916.
[32] Gopalakrishna P, Chaubey S K, Manogaran P S, et al. Modulation of alpha5beta1 integrin functions by the phospholipid and cholesterol  contents of cell membranes[J].J Cell Biochem, 2000,77(4):517-528.
[33] Choi W S, Lee G, Song W H, et al. The CH25H-CYP7B1-RORalpha axis of cholesterol metabolism regulates Osteoarthritis [J].Nature, 2019,566(7743):254-258.DOI:10.1038/s41586-019-0920-1.
[34] He H, Lu M, Shi H, et al. Vaspin regulated cartilage cholesterol metabolism through miR155/LXRalpha and participated in the occurrence of Osteoarthritis in rats[J].Life Sci, 2021,269:119096.DOI:10.1016/j.lfs.2021.119096.
[35] Bolduc J A, Collins J A, Loeser R F. Reactive oxygen species, aging and articular cartilage homeostasis[J]. Free Radic Biol Med, 2019,132:73-82.DOI:10.1016/j.freeradbiomed.2018.08.038.
[36] Lepetsos P, Papavassiliou A G.ROS/oxidative stress signaling in Osteoarthritis [J].Biochim Biophys Acta, 2016,1862(4):576-591.DOI:10.1016/j.bbadis.2016.01.003.
[37] Altindag O, Erel O, Aksoy N, et al. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis[J]. Rheumatol Int, 2007,27(4):339-344.DOI:10.1007/s00296-006-0247-8.
[38] Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species[J].Trends Pharmacol Sci, 2006,27(12):639-645.DOI:10.1016/j.tips.2006.10.005.
[39] Ersoy Y, Ozerol E, Baysal O, et al. Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and Osteoarthritis [J].Ann Rheum Dis, 2002,61(1):76-78.DOI:10.1136/ard.61.1.76.
[40] Li J, Dong S.The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation[J].Stem Cells Int, 2016,2016:2470351.DOI:10.1155/2016/2470351.
[41] Li K, Deng G, Deng Y, et al.High Cholesterol inhibits tendon-related gene expressions in tendon-derived stem  cells through reactive oxygen species-activated nuclear factor-kappaB signaling[J].J Cell Physiol, 2019,234(10):18017-18028.DOI:10.1002/jcp.28433.
[42] Day C P, James O F. Steatohepatitis: a tale of two “hits”?[J].Gastroenterology, 1998,114(4):842-845.DOI:10.1016/s0016-5085(98)70599-2.
[43] Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)[J].Prog Lipid Res, 2009,48(1):1-26.DOI:10.1016/j.plipres.2008.08.001.
[44] Zhang X, Shen J, Man K, et al.CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker  of non-alcoholic steatohepatitis[J]. J Hepatol, 2014,61(6):1365-1375.DOI:10.1016/j.jhep.2014.07.006.
[45] Ding C, Zhao Y, Shi X, et al.New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats[J].Sci Rep, 2016,6:28734.DOI:10.1038/srep28734.
[46] Caron J P, Fernandes J C, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental Osteoarthritis. Suppression of collagenase-1 expression[J].Arthritis Rheum, 1996,39(9):1535-1544.DOI:10.1002/art.1780390914.
[47] Dougados M, Emery P, Lemmel E M, et al. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data[J].J Rheumatol, 2003,30(12):2572-2579.
[48] Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade[J].Ann Rheum Dis, 2006,65(4):555-556.DOI:10.1136/ard.2006.053272.
[49] Magnano M D, Chakravarty E F, Broudy C, et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory Osteoarthritis of the hands[J]. J Rheumatol, 2007,34(6):1323-1327.
[50] Hochberg M C, Altman R D, April K T, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in Osteoarthritis of the hand, hip,  and knee[J].Arthritis Care Res (Hoboken), 2012,64(4):465-474.DOI:10.1002/acr.21596.
[51] Dje N P, Riediger F, Vardarova K, et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2009,29(3):380-386.DOI:10.1161/ATVBAHA.108.178319.
[52] Maki-Petaja K M, Booth A D, Hall F C, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis[J].J Am Coll Cardiol, 2007,50(9):852-858.DOI:10.1016/j.jacc.2007.04.076.
[53] Wei W, Clockaerts S, Bastiaansen-Jenniskens Y M, et al. Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice[J].Osteoarthritis Cartilage, 2014,22(2):293-301.DOI:10.1016/j.joca.2013.11.009.
[54] Akasaki Y, Matsuda S, Nakayama K, et al. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation[J].Osteoarthritis Cartilage, 2009,17(2):235-243.DOI:10.1016/j.joca.2008.06.012.
[55] Aktas E, Sener E, Gocun P U. Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3[J].J Orthop Traumatol, 2011,12(3):145-151.DOI:10.1007/s10195-011-0154-y.
[56] Conaghan P G.The effects of statins on Osteoarthritis structural progression: another glimpse  of the Holy Grail?[J]. Ann Rheum Dis, 2012,71(5):633-634.DOI:10.1136/annrheumdis-2011-201135.
[57] Clockaerts S, Van Osch G J, Bastiaansen-Jenniskens Y M, et al. Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study[J].Ann Rheum Dis, 2012,71(5):642-647.DOI:10.1136/annrheumdis-2011-200092.
[58] Kadam U T, Blagojevic M, Belcher J. Statin use and clinical osteoarthritis in the general population: a longitudinal  study[J].J Gen Intern Med, 2013,28(7):943-949.DOI:10.1007/s11606-013-2382-8.
[59] Valdes A M, Zhang W, Muir K, et al. Use of statins is associated with a lower prevalence of generalised Osteoarthritis [J].Ann Rheum Dis, 2014,73(5):943-945.DOI:10.1136/annrheumdis-2013-204382.
[60] Beattie M S, Lane N E, Hung Y Y, et al. Association of statin use and development and progression of hip osteoarthritis in elderly women[J].J Rheumatol, 2005,32(1):106-110.
[61] Riddle D L, Moxley G, Dumenci L. Associations between statin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis[J].Ann Rheum Dis, 2013,72(2):196-203.DOI:10.1136/annrheumdis-2012-202159.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4576
Visits: 198365

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.